US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist

2.155
-0.022-0.99%

Close May 10 16:00 ET

2.150
-0.005-0.23%

Post 19:47 ET

18.22MMarket Cap-1456P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

(Q1)Jul 31, 2022

(FY)Apr 30, 2022

(Q4)Apr 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

20.35%1.87M

-39.21%1.41M

23.49%2.08M

46.98%6.46M

-40.09%903.28K

81.40%1.55M

130.74%2.32M

64.23%1.68M

21.23%4.39M

45.68%1.51M

Selling and administrative expenses

-10.72%1.12M

-36.89%1.1M

45.01%1.73M

120.37%4.75M

10.25%562.15K

191.44%1.26M

187.82%1.74M

95.40%1.19M

68.78%2.16M

12.55%509.89K

-General and administrative expense

-10.72%1.12M

-36.89%1.1M

45.01%1.73M

120.37%4.75M

10.25%562.15K

191.44%1.26M

187.82%1.74M

95.40%1.19M

68.78%2.16M

12.55%509.89K

Research and development costs

179.19%126.73K

-53.91%82.03K

-34.40%104.48K

-32.19%468.54K

-66.20%85.87K

-71.28%45.39K

31.63%178K

10.90%159.27K

-24.59%690.94K

-20.67%254.07K

Other operating expenses

146.77%620.78K

-42.77%229.16K

-26.77%240K

-20.05%1.23M

-65.68%255.26K

-5.82%251.56K

51.10%400.42K

21.88%327.72K

8.09%1.54M

184.28%743.74K

Operating profit

-20.35%-1.87M

39.21%-1.41M

-23.49%-2.08M

-46.98%-6.46M

40.09%-903.28K

-81.40%-1.55M

-130.74%-2.32M

-64.23%-1.68M

-21.23%-4.39M

-45.68%-1.51M

Net non-operating interest income expense

38.65%881.66K

103.61%894.18K

527.86%875.88K

1,133.01%1.94M

735.12%722.94K

1,298.82%635.89K

1,617.05%439.17K

29,971.95%139.5K

5,258.77%157.14K

8,423.75%86.57K

Non-operating interest income

38.65%881.66K

103.61%894.18K

527.86%875.88K

1,129.03%1.94M

735.12%722.94K

1,298.82%635.89K

1,614.24%439.17K

--139.5K

--157.65K

--86.57K

Non-operating interest expense

----

--0

----

-83.29%509

--0

Other net income (expense)

140.42%367.75K

312,504.06%3.31M

-50,689.78%-1.98M

4,816.37%202K

3,533.44%54.01K

24,379.05%152.96K

-120.42%-1.06K

-144.13%-3.91K

-105.73%-4.28K

-102.07%-1.57K

Gain on sale of security

--368K

--3.31M

---1.98M

----

Other non- operating income (expenses)

-100.17%-253

27.69%-765

52.66%-1.85K

4,816.37%202K

3,533.44%54.01K

24,379.05%152.96K

-120.42%-1.06K

-144.13%-3.91K

-260.52%-4.28K

---1.57K

Income before tax

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-19.37%-4.24M

-48.20%-1.42M

Income tax

Net income

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-19.37%-4.24M

-48.20%-1.42M

Net income continuous Operations

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-19.37%-4.24M

-48.20%-1.42M

Minority interest income

Net income attributable to the parent company

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-19.37%-4.24M

-48.20%-1.42M

Preferred stock dividends

781.51K

586.89K

319.85K

Other preferred stock dividends

4.22M

4.46M

Net income attributable to common stockholders

-635.49%-5.62M

-20.08%-2.26M

-126.74%-3.5M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-19.37%-4.24M

-48.20%-1.42M

Basic earnings per share

-1,525.00%-0.65

-188.89%-0.26

-300.00%-0.28

18.52%-0.22

83.33%-0.01

0.00%-0.04

-50.00%-0.09

89.06%-0.07

88.98%-0.27

90.16%-0.06

Diluted earnings per share

-1,525.00%-0.65

-188.89%-0.26

-300.00%-0.28

18.52%-0.22

83.33%-0.01

0.00%-0.04

-50.00%-0.09

89.06%-0.07

88.98%-0.27

90.16%-0.06

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022	(Q1)Jul 31, 2022	(FY)Apr 30, 2022	(Q4)Apr 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	20.35%1.87M	-39.21%1.41M	23.49%2.08M	46.98%6.46M	-40.09%903.28K	81.40%1.55M	130.74%2.32M	64.23%1.68M	21.23%4.39M	45.68%1.51M
Selling and administrative expenses	-10.72%1.12M	-36.89%1.1M	45.01%1.73M	120.37%4.75M	10.25%562.15K	191.44%1.26M	187.82%1.74M	95.40%1.19M	68.78%2.16M	12.55%509.89K
-General and administrative expense	-10.72%1.12M	-36.89%1.1M	45.01%1.73M	120.37%4.75M	10.25%562.15K	191.44%1.26M	187.82%1.74M	95.40%1.19M	68.78%2.16M	12.55%509.89K
Research and development costs	179.19%126.73K	-53.91%82.03K	-34.40%104.48K	-32.19%468.54K	-66.20%85.87K	-71.28%45.39K	31.63%178K	10.90%159.27K	-24.59%690.94K	-20.67%254.07K
Other operating expenses	146.77%620.78K	-42.77%229.16K	-26.77%240K	-20.05%1.23M	-65.68%255.26K	-5.82%251.56K	51.10%400.42K	21.88%327.72K	8.09%1.54M	184.28%743.74K
Operating profit	-20.35%-1.87M	39.21%-1.41M	-23.49%-2.08M	-46.98%-6.46M	40.09%-903.28K	-81.40%-1.55M	-130.74%-2.32M	-64.23%-1.68M	-21.23%-4.39M	-45.68%-1.51M
Net non-operating interest income expense	38.65%881.66K	103.61%894.18K	527.86%875.88K	1,133.01%1.94M	735.12%722.94K	1,298.82%635.89K	1,617.05%439.17K	29,971.95%139.5K	5,258.77%157.14K	8,423.75%86.57K
Non-operating interest income	38.65%881.66K	103.61%894.18K	527.86%875.88K	1,129.03%1.94M	735.12%722.94K	1,298.82%635.89K	1,614.24%439.17K	--139.5K	--157.65K	--86.57K
Non-operating interest expense	----	----	----	--0	----	----	----	----	-83.29%509	--0
Other net income (expense)	140.42%367.75K	312,504.06%3.31M	-50,689.78%-1.98M	4,816.37%202K	3,533.44%54.01K	24,379.05%152.96K	-120.42%-1.06K	-144.13%-3.91K	-105.73%-4.28K	-102.07%-1.57K
Gain on sale of security	--368K	--3.31M	---1.98M	----	----	----	----	----	----	----
Other non- operating income (expenses)	-100.17%-253	27.69%-765	52.66%-1.85K	4,816.37%202K	3,533.44%54.01K	24,379.05%152.96K	-120.42%-1.06K	-144.13%-3.91K	-260.52%-4.28K	---1.57K
Income before tax	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M	-19.37%-4.24M	-48.20%-1.42M
Income tax
Net income	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M	-19.37%-4.24M	-48.20%-1.42M
Net income continuous Operations	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M	-19.37%-4.24M	-48.20%-1.42M
Minority interest income
Net income attributable to the parent company	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M	-19.37%-4.24M	-48.20%-1.42M
Preferred stock dividends	781.51K	586.89K	319.85K
Other preferred stock dividends	4.22M	4.46M				0	0
Net income attributable to common stockholders	-635.49%-5.62M	-20.08%-2.26M	-126.74%-3.5M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M	-19.37%-4.24M	-48.20%-1.42M
Basic earnings per share	-1,525.00%-0.65	-188.89%-0.26	-300.00%-0.28	18.52%-0.22	83.33%-0.01	0.00%-0.04	-50.00%-0.09	89.06%-0.07	88.98%-0.27	90.16%-0.06
Diluted earnings per share	-1,525.00%-0.65	-188.89%-0.26	-300.00%-0.28	18.52%-0.22	83.33%-0.01	0.00%-0.04	-50.00%-0.09	89.06%-0.07	88.98%-0.27	90.16%-0.06
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall